# Amazon Bio Discovery develops three AI approaches for antibody drug design

Amazon Science said Amazon Bio Discovery developed MochiBind, CA-MAP, and an agent-guided design system to accelerate antibody drug design, reporting 46 lab-validated hits against a novel cancer target.

Language: en
Time zone: America/Los_Angeles
Current time (UTC, cached as of): 2026-11-10T06:08:00.000Z
Query date (America/Los_Angeles): 2026-11-09

HTML: https://didcodexreset.com/news/c0d7efb8fe2b42abbd531d7a.html

Content language: en
Localization state: sameLanguage

Source: Amazon Science · Published 9/21/2026, 12:33:33

Amazon Science said Amazon Bio Discovery developed three AI approaches to accelerate antibody drug design: **MochiBind** for sequence-based affinity ranking, **CA-MAP** for developability prediction with batch effect correction, and an **agent-guided design system**.

The agent-guided system was described as producing **46 lab-validated hits** against a novel cancer target. Amazon Science linked additional details at [amazon.science](https://www.amazon.science/blog/advancing-ai-for-biology-teaching-models-to-design-and-characterize-antibodies?utm_campaign=advancing-ai-for-biology-teaching-models-to-design-and-characterize-antibodies&utm_medium=organic-asw&utm_source=twitter&utm_content=2026-09-21-advancing-ai-for-biology-teaching-models-to-design-and-characterize-antibodies&utm_term=2026-september).

Tags: Amazon, Antibody design, Drug discovery, AI research

[View original post](https://x.com/AmazonScience/status/2102117413361766747)